Oral estradiol modulated GHRP-2's GH-stimulating effects in postmenopausal women, increasing IGF-1 response but altering GH pulsatile dynamics, revealing important sex hormone-GH peptide interactions.
Estrogen modulates GHRP-2Oral estradiol increased IGF-1 response to GHRP-2 but modified GH pulsatile dynamics in postmenopausal women
What the researchers found
Oral estradiol supplementation in postmenopausal women modulated continuous GHRP-2-driven GH secretion, increasing IGF-1 response but altering GH pulse dynamics, revealing estrogen-GH secretagogue interactions important for clinical dosing.
Why it matters
Millions of postmenopausal women use estrogen therapy and may also benefit from GH secretagogues. Understanding how these interact is essential for safe, effective combination therapy.
How the study worked
Randomized study in 10 healthy postmenopausal women. Oral estradiol supplementation followed by 24-hour continuous GHRP-2 infusion with 10-minute blood sampling. GH deconvolution analysis and IGF-1 measurement.
What this study cannot tell us
Small study (10 women). Oral estradiol (which undergoes first-pass liver metabolism) may differ from transdermal estradiol in GH axis effects. Acute estrogen effects may not reflect chronic use.
How to read the evidence
Strong evidence from a well-designed study with intensive hormonal profiling in the relevant clinical population, limited by small sample size.
When this study was published
Published in 2000. The interaction between estrogen and GH secretagogues is recognized as clinically important, with route-of-administration effects further characterized.
The bigger picture
Hormone therapies don't work in isolation. Estrogen's effects on the GH axis demonstrate that menopause management must consider how reproductive hormones affect other endocrine systems.
Questions still open
- Does transdermal estradiol produce different GHRP-2 interactions?
- Should GH secretagogue doses be adjusted in women on estrogen?
- Does the route of estrogen administration matter for GH axis effects?
Common questions
Does estrogen affect how GH peptides work?
Why does the estrogen route matter?
Read the original research
Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
The Journal of clinical endocrinology and metabolism, 85(8), 2649-59
Citation
Shah, N; Evans, W S; Bowers, C Y; Veldhuis, J D. (2000). Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.. The Journal of clinical endocrinology and metabolism, 85(8), 2649-59.